Available Structures

77 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure of activated receptor tyrosine kinase in complex with substrates Heteromer
P10686;
464-770
98.7DVT;ACP;MG;
Cryo EM map of full length PLC gamma 2 and FGFR1 Kinase Domain Heteromer
P16885;
463-769
100
Crystal structure of a monomeric human FGF9 in complex with the ectodomain of human FGFR1c Heteromer
P31371;
147-360
99.04SO4;
Crystal Structure of FGF1 complexed with the ectodomain of FGFR1c exhibiting an ordered ligand spec… Heteromer
P05230;
147-359
99.53SGN;
CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1… Heteromer
P05230;
147-359
100.0SO4;
Crystal Structure of a 1:1:1 FGF23-FGFR1c-aKlotho Ternary Complex Heteromer
Q9GZV9; Q9UEF7;
149-361
99.53NAG;ZN;
Cryo-EM Structure of FGF23-FGFR1c-aKlotho-HS Quaternary Complex Heteromer
Q9GZV9; Q9UEF7;
148-360
100SGN;ZN;CU;
CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX Heteromer
P09038;
149-359
99.53SO4;
CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX Heteromer
P09038;
149-359
99.53SGN;SGN;
Structural Basis of SNT PTB Domain Interactions with Distinct Neurotrophic Receptors Heteromer
Q8WU20;
409-430
100
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo…homo-2-mer458-765
100.0SO4;EDO;2K7;
Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5…homo-2-mer459-765
99.66VM1;PO4;
Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou…homo-2-mer460-765
99.64SO4; 10×EDO;0S9;
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo…homo-2-mer460-765
99.64EDO;SO4;2K5;
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1homo-2-mer461-762
100.0
Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou…homo-2-mer461-762
100.00S8;EDO;SO4;
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074homo-2-mer461-762
100.0PD1;
Crystal structure of Human Fibroblast Growth Factor Receptor 1 Kinase domain in complex with compou…homo-2-mer461-762
100.00S7;EDO;
Crystal Structure of activated receptor tyrosine kinase in complex with substratesmonomer463-774
99.65GQL;
Native FGFR1 with an inhibitormonomer458-765
100.0CL;38O;
FGFR1 mutant with an inhibitormonomer458-764
99.6638O;CL;
Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETH…monomer458-764
99.3566T;
Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domainmonomer458-764
99.67SO4;
Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-…monomer458-764
99.0266T;MG;
FGFR1 kinase domain with sulfatinibmonomer460-765
99.67UKI;SO4;GOL;
Crystal structure of FGFR1 kinase domain with Pemigatinibmonomer459-764
99.678ZF;SO4;
FGFR1 kinase domain with a covalent inhibitor 10hmonomer461-765
99.67SO4;A1LWW;
Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M), apomonomer460-764
99.02
Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethox…monomer461-765
99.3407J;SO4;
Structure of the mutant Fibroblast Growth Factor receptor 1monomer461-765
99.02
Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.monomer462-765
99.31SO4;EDO;O21;
Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527monomer463-765
99.019ES;SO4;EDO;
FGFR1 kinase domain with a dual-warhead covalent inhibitor CXF-007monomer462-764
100.0A1LVQ;SO4;
DISEASE LINKED MUTATION IN FGFRmonomer460-762
98.99SO4;ACT;
FGFR1 in complex with dovitinibmonomer464-766
100.0EDO;38O;SO4;
FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylph…monomer463-765
100.0SO4;XL6;
FGFR1 kinase domain with a covalent inhibitor 9gmonomer463-765
100.0A1LW9;SO4;
FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693monomer464-765
99.66SO4;5SF;
FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 38.monomer464-765
100.047I;SO4;EDO;
FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34.monomer464-765
100.042I;SO4;EDO;
Crystal structure of FGFR1 kinase domain in complex with compound 3monomer464-765
99.66AXU;
Crystal structure of FGFR1 kinase domain in complex with 7nmonomer464-765
99.664UT;
TAS-120 in reversible binding mode with FGFR1monomer464-765
99.64TZ0;
FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-methoxybenzyl)-7-azaindolemonomer464-765
99.66C4F;
FGFR1 ligand complexmonomer464-765
99.66SO4;EDO;XOJ;
FGFR1 kinase complex with inhibitor SN36985monomer464-765
99.64YY7;SO4;
TAS-120 covalent complex with FGFR1monomer464-765
99.64TZ0;SO4;
FGFR1 kinase domain complex with SN37333 in reversible binding modemonomer464-765
100.0YY9;
FGFR1 kinase domain complexed with FIIN-1monomer464-765
99.64MK9;SO4;
FGFR1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamidemonomer464-765
100.0WP1;
Fibroblast growth factor receptor 1 kinase in complex with JK-P5monomer464-765
99.33EDO;JVT;SO4;
Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.monomer462-763
99.3O1Y;SO4;
Structure of FGFR1 in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-…monomer465-765
99.2966T;
FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 19.monomer465-765
99.65466;SO4;EDO;CL;
Human FGF in complex with a covalent inhibitormonomer464-764
99.659K5;SO4;
Fibroblast growth factor receptor 1 kinase in complex with JK-P3monomer465-765
99.34EDO;4Y0;PPI;SO4;
FGFR1 kinase complex with inhibitor SN37118monomer465-765
100.0YY4;
Human FGF in complex with a covalent inhibitormonomer464-764
99.66SO4;GOL;9K8;
Crystal structure of the catalytic domain of FGFR1 kinase in complex with ARQ 069monomer461-761
99.643RH;SO4;EDO;
FGFR1 kinase complex with inhibitor SN37116monomer465-765
99.64YY6;
Crystal structure of FGFR1 (C488A, C584C) in complex with 6-(7-((1-aminocyclopropyl) methoxy)-6-met…monomer465-765
100.0
FGFR1 kinase complex with inhibitor SN37115monomer465-765
99.64YY5;SO4;
FGFR1 Apo structuremonomer462-762
99.66PEG;CL;
FGFR1 in complex with ponatinib (co-crystallisation).monomer465-765
100.0SO4;EDO;0LI;
Human FGFR1 kinase in complex with CH5183284monomer464-763
100.0LWJ;SO4;
FGFR-1 in complex with ligand lenvatinibmonomer463-762
99.65LEV;
FGFR1 Kinase Domain Soak with Inhibitor TYRA-300monomer465-764
99.64EDO;A1AV2;SO4;
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX W…monomer464-762
100.0SU2;
Crystal structure of FGFR1 kinase domain in complex with a novel inhibitormonomer464-762
99.65960;
CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX W…monomer464-762
99.65SU1;
FGFR-1 in complex with ligand tasurgratinibmonomer464-762
100.0A1LY1;CL;
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazo…monomer465-762
100.02M2;
Solution structure of the first Ig-like domain of human fibroblast growth factor receptor 1monomer38-123
100
cFMS tyrosine kinase in complex with 4-Cyano-1H-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-pi…monomer577-597
100.0ACT;KRJ;
cFMS Tyrosine kinase in complex with 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2…monomer577-597
100.0KRL;SO4;
cFMS tyrosine kinase in complex with a pyridopyrimidinone inhibitormonomer585-597
100.0SO4;8C5;
Crystal structure of CSF1R kinase domain in complex with DP-6233monomer585-597
100.0NA;CL;I9W;

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5a46.1.Amonomer0.76464-765
38O;100.00
1ry7.1.Bmonomer0.63152-361
58.23

49 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25a46.1.Amonomer0.76462-763
38O;100.00
Isoform 21ry7.1.Bmonomer0.62152-361
58.41
Isoform 35a46.1.Amonomer0.77375-676
38O;100.00
Isoform 35w59.1.Bmonomer0.6958-271
99.11
Isoform 45a46.1.Amonomer0.76373-674
38O;100.00
Isoform 43ojv.2.Bmonomer0.6958-270
99.55
Isoform 55a46.1.Amonomer0.77304-605
38O;100.00
Isoform 65a46.1.Amonomer0.77302-603
38O;100.00
Isoform 75a46.1.Amonomer0.76462-763
38O;100.00
Isoform 71ry7.1.Bmonomer0.63150-359
56.92
Isoform 81e0o.1.Dmonomer0.69152-359
79.05
Isoform 85a46.1.Amonomer0.67464-646
88.52
Isoform 81ry7.1.Bmonomer0.64152-361
57.99
Isoform 84y61.1.Amonomer0.5333-361
21.28
Isoform 85xwu.1.Cmonomer0.5332-359
22.42
Isoform 84wrm.1.Amonomer0.5326-360
17.29
Isoform 84x9i.1.Bmonomer0.5140-359
19.86
Isoform 95a46.1.Amonomer0.68462-644
88.94
Isoform 91e0o.1.Dmonomer0.68152-359
79.05
Isoform 91ry7.1.Bmonomer0.63152-361
57.99
Isoform 96fwx.1.Amonomer0.6033-249
19.58
Isoform 95xwu.1.Amonomer0.5532-360
22.34
Isoform 94y61.1.Amonomer0.5333-361
21.28
Isoform 103ojm.1.Bmonomer0.7262-273
69.52
Isoform 101e0o.1.Bmonomer0.7162-270
78.67
Isoform 104j96.1.Amonomer0.69369-559
72.54
Isoform 113ojm.1.Bmonomer0.7362-272
69.86
Isoform 111e0o.1.Bmonomer0.7162-270
78.67
Isoform 114j96.1.Amonomer0.69367-557
72.02
Isoform 123ojm.1.Bmonomer0.712-202
69.35
Isoform 121e0o.1.Bmonomer0.691-199
79.10
Isoform 123kxx.1.Amonomer0.69301-487
85.71
Isoform 133ojm.1.Bmonomer0.713-201
69.54
Isoform 132pzr.1.Amonomer0.71303-486
70.62
Isoform 131e0o.1.Bmonomer0.691-199
79.10
Isoform 145a46.1.Amonomer0.77373-674
38O;100.00
Isoform 143ojv.2.Bmonomer0.6958-268
99.55
Isoform 152ckn.1.Amonomer0.7135-119
94.12
Isoform 167ysh.1.Cmonomer0.7259-272
77.88
Isoform 161e0o.1.Bmonomer0.7062-271
60.75
Isoform 172y8n.1.Bmonomer0.5831-57
37.04
Isoform 187ysh.1.Cmonomer0.7358-270
77.21
Isoform 181e0o.1.Bmonomer0.7059-269
60.47
Isoform 195a46.1.Amonomer0.76464-765
38O;100.00
Isoform 191ry7.1.Bmonomer0.62153-364
57.14
Isoform 205a46.1.Amonomer0.76454-755
38O;100.00
Isoform 201ry7.1.Bmonomer0.63144-353
57.63
Isoform 215a46.1.Amonomer0.75495-796
38O;100.00
Isoform 211ry7.1.Bmonomer0.60183-395
62.63